WAC 296-823-180. Additional requirements for HIV and HBV research laboratories and production facilities

Summary Your responsibility: To implement and enforce these additional rules in research laboratories and production facilities engaged in the culture, production, concentration, experimentation, and manipulation of HIV and HBV. EXEMPTION: This section does not apply to clinical or diagnostic laboratories engaged solely in the analysis of blood, tissues, or organs. Note: Production and research facilities: Hepatitis C (HCV) is the virus involved in most cases of parenterally transmitted (bloodborne) non-A, non-B hepatitis in the United States. Most individuals who contract HCV become chronically infected (85%) and develop chronic hepatitis (70%). It is recommended that you also follow these requirements for HCV production and research facilities. You must meet the requirements … in this section: Prepare, review, and update a biosafety manual WAC 296-823-18005 Follow these special practices for the work area WAC 296-823-18010 Make sure these practices for contaminated material and waste are followed WAC 296-823-18015 Make sure these special practices for personal protective equipment (PPE) and other safeguards are followed WAC 296-823-18020 Protect vacuum lines WAC 296-823-18025 Use and handle hypodermic needles and syringes appropriately and safely WAC 296-823-18030 Handle all spills and accidents properly WAC 296-823-18035 Post signs WAC 296-823-18040 Provide additional training for facility employees WAC 296-823-18045 Furnish a sink for washing hands and a readily available eye wash facility WAC 296-823-18050 Make sure these additional criteria are followed for HIV and HBV production facilities WAC 296-823-18055 You must meet the requirements … in this section: Prepare, review, and update a biosafety manual WAC 296-823-18005 Follow these special practices for the work area WAC 296-823-18010 Make sure these practices for contaminated material and waste are followed WAC 296-823-18015 Make sure these special practices for personal protective equipment (PPE) and other safeguards are followed WAC 296-823-18020 Protect vacuum lines WAC 296-823-18025 Use and handle hypodermic needles and syringes appropriately and safely WAC 296-823-18030 Handle all spills and accidents properly WAC 296-823-18035 Post signs WAC 296-823-18040 Provide additional training for facility employees WAC 296-823-18045 Furnish a sink for washing hands and a readily available eye wash facility WAC 296-823-18050 Make sure these additional criteria are followed for HIV and HBV production facilities WAC 296-823-18055